A Complimentary Webinar
MOUNTAIN VIEW, Calif., March 30 /PRNewswire/ --
- TOPIC: The state of the microRNA market and the molecule's current and potential impact on drug discovery, molecular diagnostics, and personalized therapeutics. - WHEN: Tuesday, March 31, 2009 - TIME: 3 pm EDT - LOCATION: Online with free registration - HOST: Christi Bird, Senior Research Analyst, Healthcare practice, Frost & Sullivan - GUESTS: - Dr. George Calin, Associate Professor, The University of Texas M. D. Anderson Cancer Center - Alex Amiet, Senior Product Manager, Thermo Fisher Scientific - This panel discussion will benefit life science research tools manufacturers, services providers, diagnostic companies, biotechnology companies, pharmaceutical companies, academic researchers and venture capitalists. The outlook for the microRNA market will be presented from a three-pronged perspective of an industry analyst with knowledge of the market, a microRNA expert from academia, and a provider of microRNA tools and services.
"The rapid discoveries linking microRNAs to various diseases have propelled the microRNA field and tools market in recent years. Moving forward, however, the microRNA field requires more innovative studies of larger scope to make good on its lofty promise," says Bird of Frost & Sullivan.
|SOURCE Frost & Sullivan|
Copyright©2009 PR Newswire.
All rights reserved